Ülke: Almanya Borsa: Frankfurt Sektör: Sağlık Hizmetleri Endüstri: Biyoteknoloji Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Almanya (648)
- {{country.name}}
- Tüm ülkeler
- Almanya (648)
Frankfurt (648)
- {{item.name}}
- Tüm borsalar
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (23)
Sağlık Hizmetleri (648)
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (648)
Biyoteknoloji (648)
- {{item.name}}
- Tüm Sektörler
- Biyoteknoloji (648)
- İlaç Üreticileri-Genel (45)
- İlaç Üreticileri-Özel ve Genel (277)
- Sağlık Hizmeti Planları (9)
- Tıbbi Bakım Tesisleri (93)
- Farmasötik Perakendeciler (21)
- Sağlık Bilgileri Hizmetleri (81)
- Tıbbi Cihazlar (202)
- Tıbbi Ekipmanlar ve Malzemeler (106)
- Teşhis ve Araştırma (102)
- Medikal Ürün Dağıtımı (22)
Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
---|
Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
---|---|---|---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
WuXi Biologics (Cayman) Inc. 1FW2.F | $2.7 2.95 USD |
-0.85
|
$11.12B 12.16B USD | $510 557.5 USD | $2.7 2.95 USD | $2.7 2.95 USD | $11.12B 12.16B USD | 29.96 | $0.09 0.1 USD | |
Sino Biopharmaceutical Limited SMZ1.F | $0.53 0.58 USD |
-1.38
|
$9.71B 10.62B USD | $4K 4.37K USD | $0.53 0.58 USD | $0.53 0.58 USD | $9.71B 10.62B USD | 52.85 | $0.01 0.01 USD | |
CureVac N.V. 5CV.F | $4.75 5.19 USD |
-0.42
|
$1.07B 1.17B USD | $3.75K 4.1K USD | $4.72 5.16 USD | $4.8 5.25 USD | $1.07B 1.17B USD | 5.93 | $0.8 0.87 USD | |
Valneva SE AYJ.F | $2.38 2.6 USD |
-4.03
|
$407.7M 445.67M USD | $12.84K 14.03K USD | $2.38 2.6 USD | $2.38 2.6 USD | $407.7M 445.67M USD | 0 | -$0.56 -0.6 USD | |
Ocugen, Inc. 2H51.F | $0.9399 1.02 USD |
-1.18
|
$273.95M 299.47M USD | $60.91K 66.58K USD | $0.9399 1.02 USD | $0.9399 1.02 USD | $273.95M 299.47M USD | 0 | -$0.17 -0.1 USD | |
Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
Immunic, Inc. 10VA.F | $0.63 0.69 USD |
-2.77
|
$60.56M 66.2M USD | $7K 7.65K USD | $0.63 0.69 USD | $0.63 0.69 USD | $60.56M 66.2M USD | 0 | -$0.83 -0.9 USD | |
Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
0
|
$55.14M 60.27M USD | $480K 524.7K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $55.14M 60.27M USD | 0 | $0 0 USD | |
Defence Therapeutics Inc. DTC.F | $0.4799 0.52 USD |
-4
|
$26.27M 28.71M USD | $5.3K 5.79K USD | $0.4799 0.52 USD | $0.4799 0.52 USD | $26.27M 28.71M USD | 0 | -$0.05 -0.05 USD | |
Active Biotech AB (publ) BTPC.F | $0.02 0.02 USD |
-10.05
|
$21.75M 23.78M USD | $51.86K 56.69K USD | $0.02 0.02 USD | $0.02 0.02 USD | $21.75M 23.78M USD | 0 | -$0.01 -0.01 USD | |
BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$6.54M 7.14M USD | $23K 25.14K USD | $0.01 0.01 USD | $0.01 0.01 USD | $6.54M 7.14M USD | 0 | -$0.01 -0.01 USD | |
Glow Lifetech Corp. 9DO.F | $0.02 0.02 USD |
-17.07
|
$4M 4.37M USD | $5K 5.47K USD | $0.02 0.02 USD | $0.02 0.02 USD | $4M 4.37M USD | 0 | -$0.02 -0.02 USD | |
Medigene AG MDG1.F | $0.13 0.14 USD |
-5.71
|
$1.95M 2.13M USD | $14K 15.3K USD | $0.13 0.14 USD | $0.13 0.15 USD | $1.95M 2.13M USD | 0 | -$1.21 -1.3 USD | |
BioSenic S.A. BT1.F | $0.001799 0.0019 USD |
-5.26
|
$1.36M 1.49M USD | $200K 218.63K USD | $0.001799 0.0019 USD | $0.001799 0.0019 USD | $1.36M 1.49M USD | 0 | -$0.04 -0.04 USD | |
Novo Nordisk A/S NOVA.F | $64.1 70.07 USD |
-0.77
|
$285.22B 311.78B USD | $405 442.72 USD | $63.4 69.3 USD | $64.5 70.51 USD | $285.22B 311.78B USD | 20.34 | $3.15 3.44 USD | |
Vertex Pharmaceuticals Incorporated VX1.F | $390.15 426.49 USD |
+1.89
|
$102.19B 111.7B USD | $200 218.63 USD | $390.15 426.49 USD | $390.15 426.49 USD | $102.19B 111.7B USD | 0 | -$3.33 -3.6 USD | |
CSL Limited CSJA.F | $66.5 72.69 USD |
-0.75
|
$65.63B 71.74B USD | $5 5.47 USD | $66.5 72.69 USD | $66.5 72.69 USD | $65.63B 71.74B USD | 28.05 | $2.37 2.59 USD | |
CSL Limited CSJ.F | $133.36 145.78 USD |
-1.49
|
$65.13B 71.2B USD | $5 5.47 USD | $133.36 145.78 USD | $133.36 145.78 USD | $65.13B 71.2B USD | 28.07 | $4.75 5.19 USD | |
Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
Alnylam Pharmaceuticals, Inc. DUL.F | $269.3 294.38 USD |
+1.16
|
$35.88B 39.22B USD | $30 32.79 USD | $269.3 294.38 USD | $269.3 294.38 USD | $35.88B 39.22B USD | 0 | -$1.84 -2.01 USD | |
UCB SA UNC.F | $153.75 168.07 USD |
-2.41
|
$29.33B 32.06B USD | $1 1.09 USD | $153.75 168.07 USD | $153.75 168.07 USD | $29.33B 32.06B USD | 28.05 | $5.48 5.99 USD | |
UCB SA UNC0.F | $75.5 82.53 USD |
-2.58
|
$29.28B 32.01B USD | $50 54.66 USD | $75.5 82.53 USD | $75.5 82.53 USD | $29.28B 32.01B USD | 27.55 | $2.74 3 USD | |
argenx SE 1AEA.F | $464 507.21 USD |
0
|
$28.87B 31.56B USD | $12 13.12 USD | $464 507.21 USD | $464 507.21 USD | $28.87B 31.56B USD | 32.47 | $14.29 15.62 USD | |
argenx SE 1AE.F | $468.4 512.02 USD |
-0.95
|
$28.6B 31.26B USD | $2 2.19 USD | $468.4 512.02 USD | $468.4 512.02 USD | $28.6B 31.26B USD | 32.80 | $14.28 15.61 USD | |
BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
+0.58
|
$25.73B 28.13B USD | $509 556.41 USD | $16.6 18.15 USD | $16.6 18.15 USD | $25.73B 28.13B USD | 0 | -$0.24 -0.2 USD | |
BeOne Medicines Ltd. 49BA.F | $218 238.3 USD |
0
|
$25.61B 27.99B USD | $6 6.56 USD | $218 238.3 USD | $218 238.3 USD | $25.61B 27.99B USD | 0 | -$3.16 -3.4 USD | |
BioNTech SE 22UA.F | $90.5 98.93 USD |
-0.88
|
$21.76B 23.78B USD | $1.05K 1.15K USD | $90.2 98.6 USD | $90.5 98.93 USD | $21.76B 23.78B USD | 0 | -$3.19 -3.4 USD | |
Royalty Pharma plc RPD.F | $30.1 32.9 USD |
+1.11
|
$17.28B 18.89B USD | $150 163.97 USD | $30.1 32.9 USD | $30.1 32.9 USD | $17.28B 18.89B USD | 14.13 | $2.13 2.33 USD | |
Insmed Incorporated IM8N.F | $86 94.01 USD |
-0.58
|
$16.36B 17.88B USD | $124 135.55 USD | $86 94.01 USD | $86 94.01 USD | $16.36B 17.88B USD | 0 | -$5.16 -5.6 USD | |
Innovent Biologics, Inc. 6IB.F | $8.55 9.35 USD |
-0.58
|
$14.2B 15.53B USD | $1.1K 1.2K USD | $8.55 9.35 USD | $8.55 9.35 USD | $14.2B 15.53B USD | 0 | -$0.01 -0.01 USD | |
United Therapeutics Corporation UTH.F | $251.9 275.36 USD |
+1.61
|
$11.65B 12.73B USD | $80 87.45 USD | $251.9 275.36 USD | $251.9 275.36 USD | $11.65B 12.73B USD | 11.52 | $21.86 23.9 USD | |
Incyte Corporation ICY.F | $59.3 64.82 USD |
-0.4
|
$11.48B 12.55B USD | $1.36K 1.49K USD | $59.3 64.82 USD | $59.3 64.82 USD | $11.48B 12.55B USD | 348.82 | $0.17 0.19 USD | |
WuXi Biologics (Cayman) Inc. 1FW1.F | $5.2 5.68 USD |
-3.7
|
$11.11B 12.14B USD | $208 227.37 USD | $5.2 5.68 USD | $5.2 5.68 USD | $11.11B 12.14B USD | 27.36 | $0.19 0.21 USD | |
Verona Pharma plc I9SA.F | $76.8 83.95 USD |
-4
|
$10.13B 11.07B USD | $50 54.66 USD | $76.8 83.95 USD | $76.8 83.95 USD | $10.13B 11.07B USD | 0 | -$1.74 -1.9 USD | |
Exelixis, Inc. EX9.F | $35.13 38.4 USD |
-1.38
|
$9.58B 10.47B USD | $30 32.79 USD | $35.13 38.4 USD | $35.13 38.4 USD | $9.58B 10.47B USD | 18.39 | $1.91 2.09 USD | |
BioMarin Pharmaceutical Inc. BM8.F | $47.89 52.35 USD |
+0.59
|
$9.28B 10.15B USD | $20 21.86 USD | $47.89 52.35 USD | $47.89 52.35 USD | $9.28B 10.15B USD | 20.37 | $2.35 2.57 USD | |
Akeso, Inc. 4RY.F | $10 10.93 USD |
-2.91
|
$9.04B 9.88B USD | $258 282.03 USD | $10 10.93 USD | $10 10.93 USD | $9.04B 9.88B USD | 0 | -$0.07 -0.07 USD | |
Ascendis Pharma A/S A71.F | $147 160.69 USD |
-1.34
|
$8.89B 9.72B USD | $1 1.09 USD | $147 160.69 USD | $147 160.69 USD | $8.89B 9.72B USD | 0 | -$5.81 -6.3 USD | |
Moderna, Inc. 0QF.F | $21.97 24.01 USD |
-0.16
|
$8.54B 9.34B USD | $124 135.55 USD | $21.97 24.01 USD | $21.97 24.01 USD | $8.54B 9.34B USD | 0 | -$7.6 -8.3 USD | |
ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
Blueprint Medicines Corporation 2L9.F | $110.75 121.06 USD |
+0.73
|
$7.27B 7.95B USD | $135 147.57 USD | $110.75 121.06 USD | $110.75 121.06 USD | $7.27B 7.95B USD | 0 | -$2.19 -2.3 USD | |
Bio-Techne Corporation TE1.F | $42.8 46.79 USD |
+0.94
|
$6.91B 7.55B USD | $50 54.66 USD | $42.8 46.79 USD | $42.8 46.79 USD | $6.91B 7.55B USD | 59.44 | $0.72 0.79 USD | |
Roivant Sciences Ltd. 87S.F | $9.82 10.74 USD |
+3.24
|
$6.75B 7.38B USD | $600 655.88 USD | $9.82 10.74 USD | $9.82 10.74 USD | $6.75B 7.38B USD | 0 | -$0.65 -0.7 USD | |
Revolution Medicines, Inc. 42Z.F | $34.4 37.6 USD |
+2.38
|
$6.63B 7.25B USD | $50 54.66 USD | $34.4 37.6 USD | $34.4 37.6 USD | $6.63B 7.25B USD | 0 | -$3.49 -3.8 USD | |
BridgeBio Pharma, Inc. 2CL.F | $34.48 37.69 USD |
-0.09
|
$6.61B 7.22B USD | $35 38.26 USD | $34.48 37.69 USD | $34.48 37.69 USD | $6.61B 7.22B USD | 0 | -$3.1 -3.3 USD | |
Corcept Therapeutics Incorporated HTD.F | $61.28 66.99 USD |
-0.91
|
$6.52B 7.13B USD | $11 12.02 USD | $61.28 66.99 USD | $61.28 66.99 USD | $6.52B 7.13B USD | 61.28 | $1 1.09 USD | |
Sirius XM Holdings Inc. R 3HY.F | $18.6 20.33 USD |
+1.36
|
$6.41B 7.01B USD | $66 72.15 USD | $18.6 20.33 USD | $18.6 20.33 USD | $6.41B 7.01B USD | 0 | -$4.39 -4.7 USD | |
Halozyme Therapeutics, Inc. RV7.F | $46.16 50.46 USD |
+0.46
|
$5.73B 6.26B USD | $40 43.73 USD | $46.16 50.46 USD | $46.16 50.46 USD | $5.73B 6.26B USD | 14.07 | $3.28 3.59 USD | |
Jazz Pharmaceuticals plc J7Z.F | $93.02 101.68 USD |
-1.25
|
$5.63B 6.16B USD | $7 7.65 USD | $93.02 101.68 USD | $93.02 101.68 USD | $5.63B 6.16B USD | 14.51 | $6.41 7.01 USD | |
Legend Biotech Corporation 9LB.F | $30 32.79 USD |
-0.66
|
$5.56B 6.07B USD | $140 153.04 USD | $30 32.79 USD | $30 32.79 USD | $5.56B 6.07B USD | 0 | -$1.03 -1.1 USD | |
Financière de Tubize SA FTD.F | $123 134.46 USD |
-2.07
|
$5.53B 6.04B USD | $70 76.52 USD | $123 134.46 USD | $123 134.46 USD | $5.53B 6.04B USD | 60.89 | $2.02 2.21 USD | |
Madrigal Pharmaceuticals, Inc. YDO1.F | $243.7 266.4 USD |
-1.14
|
$5.41B 5.91B USD | $20 21.86 USD | $243.7 266.4 USD | $243.7 266.4 USD | $5.41B 5.91B USD | 0 | -$15.52 -16.9 USD | |
ALK-Abelló A/S 4AJ0.F | $24 26.24 USD |
0
|
$5.35B 5.85B USD | $50 54.66 USD | $24 26.24 USD | $24 26.24 USD | $5.35B 5.85B USD | 42.85 | $0.56 0.61 USD | |
3SBio Inc. 83B.F | $2.24 2.45 USD |
-5.08
|
$5.32B 5.82B USD | $3.97K 4.34K USD | $2.24 2.45 USD | $2.24 2.45 USD | $5.32B 5.82B USD | 22.39 | $0.1 0.11 USD | |
Ionis Pharmaceuticals, Inc. ISI.F | $31.98 34.96 USD |
+2.47
|
$5.26B 5.75B USD | $235 256.89 USD | $31.98 34.96 USD | $31.98 34.96 USD | $5.26B 5.75B USD | 0 | -$2.6 -2.8 USD | |
Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
TG Therapeutics, Inc. NKB2.F | $30.28 33.1 USD |
-1.42
|
$4.81B 5.25B USD | $50 54.66 USD | $30.28 33.1 USD | $30.28 33.1 USD | $4.81B 5.25B USD | 137.63 | $0.22 0.24 USD | |
Axsome Therapeutics, Inc. 19X.F | $90.3 98.71 USD |
+3.53
|
$4.57B 4.99B USD | $21 22.96 USD | $90.3 98.71 USD | $90.3 98.71 USD | $4.57B 4.99B USD | 0 | -$5.02 -5.4 USD | |
Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
Akero Therapeutics, Inc. 0K4.F | $47.56 51.99 USD |
-0.83
|
$3.79B 4.14B USD | $150 163.97 USD | $47.56 51.99 USD | $47.56 51.99 USD | $3.79B 4.14B USD | 0 | -$3.27 -3.5 USD | |
Vaxcyte, Inc. 5VA.F | $27.6 30.17 USD |
-0.72
|
$3.73B 4.08B USD | $280 306.08 USD | $27.6 30.17 USD | $27.6 30.17 USD | $3.73B 4.08B USD | 0 | -$3.48 -3.8 USD | |
Genscript Biotech Corporation G51.F | $1.57 1.72 USD |
-3.17
|
$3.51B 3.84B USD | $2.77K 3.03K USD | $1.57 1.72 USD | $1.57 1.72 USD | $3.51B 3.84B USD | 0 | -$0.07 -0.07 USD | |
CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
Cytokinetics, Incorporated KK3A.F | $28.2 30.83 USD |
+0.71
|
$3.43B 3.75B USD | $150 163.97 USD | $28.2 30.83 USD | $28.2 30.83 USD | $3.43B 3.75B USD | 0 | -$4.61 -5.03 USD | |
Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $7.5 8.2 USD |
-7.41
|
$3.42B 3.74B USD | $200 218.63 USD | $7.5 8.2 USD | $7.5 8.2 USD | $3.42B 3.74B USD | 22.05 | $0.34 0.37 USD | |
Rhythm Pharmaceuticals, Inc. 1RV.F | $53.5 58.48 USD |
0
|
$3.41B 3.72B USD | $20 21.86 USD | $53.5 58.48 USD | $53.5 58.48 USD | $3.41B 3.72B USD | 0 | -$2.44 -2.6 USD | |
Merus N.V. 2GH.F | $44.8 48.97 USD |
-0.88
|
$3.38B 3.7B USD | $106 115.87 USD | $44.8 48.97 USD | $44.8 48.97 USD | $3.38B 3.7B USD | 0 | -$3.63 -3.9 USD | |
Krystal Biotech, Inc. 4KB.F | $113.95 124.56 USD |
+1.7
|
$3.38B 3.7B USD | $190 207.7 USD | $113.95 124.56 USD | $113.95 124.56 USD | $3.38B 3.7B USD | 31.39 | $3.63 3.97 USD | |
ACADIA Pharmaceuticals Inc. DR6.F | $19.84 21.69 USD |
+0.79
|
$3.37B 3.69B USD | $100 109.31 USD | $19.84 21.69 USD | $19.84 21.69 USD | $3.37B 3.69B USD | 16.67 | $1.19 1.3 USD | |
Zai Lab Limited 1ZL.F | $30 32.79 USD |
-6.25
|
$3.36B 3.67B USD | $230 251.42 USD | $30 32.79 USD | $30 32.79 USD | $3.36B 3.67B USD | 0 | -$2.18 -2.3 USD | |
Scholar Rock Holding Corporation 2QK.F | $31.2 34.11 USD |
+10.64
|
$3.32B 3.63B USD | $114 124.62 USD | $31.2 34.11 USD | $31.2 34.11 USD | $3.32B 3.63B USD | 0 | -$2.22 -2.4 USD | |
Ultragenyx Pharmaceutical Inc. UP0.F | $32.2 35.2 USD |
+1.9
|
$3.13B 3.43B USD | $48 52.47 USD | $32.2 35.2 USD | $32.2 35.2 USD | $3.13B 3.43B USD | 0 | -$5.08 -5.5 USD | |
Camurus AB (publ) 7CA.F | $52.5 57.39 USD |
-1.13
|
$3.1B 3.39B USD | $50 54.66 USD | $52.5 57.39 USD | $52.5 57.39 USD | $3.1B 3.39B USD | 63.25 | $0.83 0.91 USD | |
Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $54.65 59.74 USD |
-1.35
|
$2.8B 3.06B USD | $35 38.26 USD | $54.65 59.74 USD | $54.65 59.74 USD | $2.8B 3.06B USD | 20.01 | $2.73 2.98 USD | |
Ascentage Pharma Group International 36X.F | $7.7 8.42 USD |
0
|
$2.72B 2.97B USD | $174 190.21 USD | $7.7 8.42 USD | $7.7 8.42 USD | $2.72B 2.97B USD | 0 | -$0.16 -0.1 USD | |
MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
Viking Therapeutics, Inc. 1VT.F | $22.42 24.51 USD |
-1.02
|
$2.54B 2.78B USD | $50 54.66 USD | $22.42 24.51 USD | $22.42 24.51 USD | $2.54B 2.78B USD | 0 | -$1.01 -1.1 USD | |
Crinetics Pharmaceuticals, Inc. 6Z4.F | $26.4 28.86 USD |
+0.76
|
$2.51B 2.74B USD | $60 65.59 USD | $26.4 28.86 USD | $26.4 28.86 USD | $2.51B 2.74B USD | 0 | -$3.31 -3.6 USD | |
Catalyst Pharmaceuticals, Inc. CN2.F | $19.53 21.34 USD |
-1.88
|
$2.38B 2.6B USD | $40 43.73 USD | $19.53 21.34 USD | $19.53 21.34 USD | $2.38B 2.6B USD | 14.25 | $1.37 1.5 USD | |
Mirum Pharmaceuticals, Inc. 08D.F | $42.8 46.79 USD |
0
|
$2.17B 2.38B USD | $26 28.42 USD | $42.8 46.79 USD | $42.8 46.79 USD | $2.17B 2.38B USD | 0 | -$1.4 -1.5 USD | |
ImmunityBio, Inc. 26CA.F | $2.45 2.68 USD |
-0.53
|
$2.16B 2.36B USD | $1K 1.09K USD | $2.45 2.68 USD | $2.45 2.68 USD | $2.16B 2.36B USD | 0 | -$0.5 -0.5 USD | |
Xenon Pharmaceuticals Inc. XP0.F | $27.6 30.17 USD |
+0.73
|
$2.15B 2.35B USD | $10 10.93 USD | $27.6 30.17 USD | $27.6 30.17 USD | $2.15B 2.35B USD | 0 | -$2.81 -3.07 USD | |
Ligand Pharmaceuticals Incorporated LGDN.F | $99.5 108.77 USD |
+2.05
|
$1.97B 2.15B USD | $20 21.86 USD | $99.5 108.77 USD | $99.5 108.77 USD | $1.97B 2.15B USD | 0 | -$6.35 -6.9 USD | |
Apellis Pharmaceuticals, Inc. 1JK.F | $14.77 16.14 USD |
+0.12
|
$1.95B 2.13B USD | $680 743.33 USD | $14.77 16.14 USD | $14.77 16.14 USD | $1.95B 2.13B USD | 0 | -$1.57 -1.7 USD | |
Arrowhead Pharmaceuticals, Inc. HDP1.F | $13.5 14.75 USD |
+0.78
|
$1.89B 2.07B USD | $80 87.45 USD | $13.5 14.75 USD | $13.5 14.75 USD | $1.89B 2.07B USD | 0 | -$1.08 -1.1 USD | |
Veracyte, Inc. 12V.F | $23.2 25.36 USD |
+0.87
|
$1.85B 2.02B USD | $1.17K 1.28K USD | $23.2 25.36 USD | $23.2 25.36 USD | $1.85B 2.02B USD | 62.70 | $0.37 0.4 USD | |
Vericel Corporation ATQP.F | $36 39.35 USD |
+0.56
|
$1.84B 2.01B USD | $22 24.05 USD | $36 39.35 USD | $36 39.35 USD | $1.84B 2.01B USD | 900.00 | $0.04 0.04 USD | |
Agios Pharmaceuticals, Inc. 8AP.F | $30.6 33.45 USD |
+2.68
|
$1.84B 2.01B USD | $54 59.03 USD | $30.6 33.45 USD | $30.6 33.45 USD | $1.84B 2.01B USD | 3.04 | $10.05 10.99 USD | |
BioCryst Pharmaceuticals, Inc. BO1.F | $8.61 9.42 USD |
+0.44
|
$1.82B 1.99B USD | $190 207.7 USD | $8.61 9.42 USD | $8.61 9.42 USD | $1.82B 1.99B USD | 0 | -$0.23 -0.2 USD | |
Bavarian Nordic A/S BV3.F | $23.3 25.47 USD |
-0.81
|
$1.82B 1.99B USD | $7 7.65 USD | $23.3 25.47 USD | $23.3 25.47 USD | $1.82B 1.99B USD | 10.35 | $2.25 2.46 USD | |
Denali Therapeutics Inc. 4DN.F | $12.2 13.33 USD |
+0.7
|
$1.8B 1.96B USD | $200 218.63 USD | $12.2 13.33 USD | $12.2 13.33 USD | $1.8B 1.96B USD | 0 | -$2.33 -2.5 USD | |
Sarepta Therapeutics, Inc. AB3A.F | $18 19.68 USD |
-4.48
|
$1.77B 1.93B USD | $1.02K 1.12K USD | $18 19.68 USD | $18 19.68 USD | $1.77B 1.93B USD | 0 | -$2.3 -2.5 USD | |
BB Biotech AG BBZA.F | $31.5 34.43 USD |
+0.48
|
$1.74B 1.9B USD | $700 765.19 USD | $31.5 34.43 USD | $31.5 34.43 USD | $1.74B 1.9B USD | 12.90 | $2.44 2.67 USD | |
Everest Medicines Limited 6HN.F | $5.2 5.68 USD |
-5.45
|
$1.71B 1.87B USD | $212 231.74 USD | $5.2 5.68 USD | $5.2 5.68 USD | $1.71B 1.87B USD | 0 | -$0.39 -0.4 USD | |
IDEAYA Biosciences, Inc. 30J.F | $18.9 20.66 USD |
0
|
$1.67B 1.82B USD | $350 382.6 USD | $18.9 20.66 USD | $18.9 20.66 USD | $1.67B 1.82B USD | 0 | -$3.18 -3.4 USD | |
Galapagos NV GXEA.F | $24.2 26.45 USD |
+0.83
|
$1.59B 1.74B USD | $4 4.37 USD | $24.2 26.45 USD | $24.2 26.45 USD | $1.59B 1.74B USD | 0 | -$2.73 -2.9 USD | |
Galapagos NV GXE.F | $24.2 26.45 USD |
0
|
$1.59B 1.74B USD | $100 109.31 USD | $24.2 26.45 USD | $24.2 26.45 USD | $1.59B 1.74B USD | 0 | -$2.73 -2.9 USD | |
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |